| PCS-2023 > 3 > 3E > 3E0 > 3E0J |
3E0 | Physiological Systems and Anatomical Regions, Introduction | |
Info: | Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products | |
3E0J | Introduction, Biliary and Pancreatic Tract | |
3E0J3 | Percutaneous | |
3E0J30 | Antineoplastic | |
3E0J304 | Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J305 | Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J30M | Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J32 | Anti-infective | |
3E0J328 | Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J329 | Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J33 | Anti-inflammatory | |
3E0J33Z | Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J36 | Nutritional Substance | |
3E0J36Z | Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J37 | Electrolytic and Water Balance Substance | |
3E0J37Z | Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J3B | Anesthetic Agent | |
3E0J3BZ | Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J3H | Radioactive Substance | |
3E0J3HZ | Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J3K | Other Diagnostic Substance | |
3E0J3KZ | Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J3N | Analgesics, Hypnotics, Sedatives | |
3E0J3NZ | Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J3T | Destructive Agent | |
3E0J3TZ | Introduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J3G | Other Therapeutic Substance | |
3E0J3GC | Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J3S | Gas | |
3E0J3SF | Introduction of Other Gas into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J3U | Pancreatic Islet Cells | |
3E0J3U0 | Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J3U1 | Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach | |
3E0J7 | Via Natural or Artificial Opening | |
3E0J70 | Antineoplastic | |
3E0J704 | Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J705 | Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J70M | Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J72 | Anti-infective | |
3E0J728 | Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J729 | Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J73 | Anti-inflammatory | |
3E0J73Z | Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J76 | Nutritional Substance | |
3E0J76Z | Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J77 | Electrolytic and Water Balance Substance | |
3E0J77Z | Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J7B | Anesthetic Agent | |
3E0J7BZ | Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J7H | Radioactive Substance | |
3E0J7HZ | Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J7K | Other Diagnostic Substance | |
3E0J7KZ | Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J7N | Analgesics, Hypnotics, Sedatives | |
3E0J7NZ | Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J7T | Destructive Agent | |
3E0J7TZ | Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J7G | Other Therapeutic Substance | |
3E0J7GC | Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J7S | Gas | |
3E0J7SF | Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J7U | Pancreatic Islet Cells | |
3E0J7U0 | Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J7U1 | Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening | |
3E0J8 | Via Natural or Artificial Opening Endoscopic | |
3E0J80 | Antineoplastic | |
3E0J804 | Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J805 | Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J80M | Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J82 | Anti-infective | |
3E0J828 | Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J829 | Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J83 | Anti-inflammatory | |
3E0J83Z | Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J86 | Nutritional Substance | |
3E0J86Z | Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J87 | Electrolytic and Water Balance Substance | |
3E0J87Z | Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J8B | Anesthetic Agent | |
3E0J8BZ | Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J8H | Radioactive Substance | |
3E0J8HZ | Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J8K | Other Diagnostic Substance | |
3E0J8KZ | Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J8N | Analgesics, Hypnotics, Sedatives | |
3E0J8NZ | Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J8T | Destructive Agent | |
3E0J8TZ | Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J8G | Other Therapeutic Substance | |
3E0J8GC | Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J8S | Gas | |
3E0J8SF | Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J8U | Pancreatic Islet Cells | |
3E0J8U0 | Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J8U1 | Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic | |
3E0J4 | Percutaneous Endoscopic | |
3E0J4G | Other Therapeutic Substance | |
3E0J4GC | Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Endoscopic Approach | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |